These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 19997603)

  • 1. Adaptive vaccination strategies to mitigate pandemic influenza: Mexico as a case study.
    Chowell G; Viboud C; Wang X; Bertozzi SM; Miller MA
    PLoS One; 2009 Dec; 4(12):e8164. PubMed ID: 19997603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modeling optimal age-specific vaccination strategies against pandemic influenza.
    Lee S; Golinski M; Chowell G
    Bull Math Biol; 2012 Apr; 74(4):958-80. PubMed ID: 22147102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimal pandemic influenza vaccine allocation strategies for the Canadian population.
    Tuite AR; Fisman DN; Kwong JC; Greer AL
    PLoS One; 2010 May; 5(5):e10520. PubMed ID: 20463898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccines against influenza A (H1N1) pandemic.
    Valdespino-Gomez JL; Garcia-Garcia L; de León-Rosales SP
    Arch Med Res; 2009 Nov; 40(8):693-704. PubMed ID: 20304259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Attitudes of the general public and general practitioners in five countries towards pandemic and seasonal influenza vaccines during season 2009/2010.
    Blank PR; Bonnelye G; Ducastel A; Szucs TD
    PLoS One; 2012; 7(10):e45450. PubMed ID: 23071519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Seasonal influenza vaccination coverage in France during two influenza seasons (2007 and 2008) and during a context of pandemic influenza A(H1N1) in 2009.
    Tuppin P; Samson S; Weill A; Ricordeau P; Allemand H
    Vaccine; 2011 Jun; 29(28):4632-7. PubMed ID: 21550376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Seasonal influenza vaccine and protection against pandemic (H1N1) 2009-associated illness among US military personnel.
    Johns MC; Eick AA; Blazes DL; Lee SE; Perdue CL; Lipnick R; Vest KG; Russell KL; DeFraites RF; Sanchez JL
    PLoS One; 2010 May; 5(5):e10722. PubMed ID: 20502705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterizing the epidemiology of the 2009 influenza A/H1N1 pandemic in Mexico.
    Chowell G; Echevarría-Zuno S; Viboud C; Simonsen L; Tamerius J; Miller MA; Borja-Aburto VH
    PLoS Med; 2011 May; 8(5):e1000436. PubMed ID: 21629683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of seasonal vaccine hemagglutinin subtype 1 (H1) epitopes in Mexican isolates of the new influenza A (H1N1) 2009 virus.
    Rodríguez-Alvarez M; Velasco-Velasco AM; Alvarez-Anell NJ; Jiménez-Corona ME; de León-Rosales SP
    Arch Med Res; 2009 Nov; 40(8):687-92. PubMed ID: 20304258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel swine-origin influenza virus A (H1N1): the first pandemic of the 21st century.
    Chang LY; Shih SR; Shao PL; Huang DT; Huang LM
    J Formos Med Assoc; 2009 Jul; 108(7):526-32. PubMed ID: 19586825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lessons from previous influenza pandemics and from the Mexican response to the current influenza pandemic.
    Del Rio C; Hernandez-Avila M
    Arch Med Res; 2009 Nov; 40(8):677-80. PubMed ID: 20304256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Seasonal influenza vaccination and the risk of infection with pandemic influenza: a possible illustration of non-specific temporary immunity following infection.
    Kelly H; Barry S; Laurie K; Mercer G
    Euro Surveill; 2010 Nov; 15(47):. PubMed ID: 21144441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Seasonal vaccine effectiveness against pandemic A/H1N1.
    Janjua NZ; Skowronski DM; Hottes TS; De Serres G; Crowcroft NS; Rosella LC
    Lancet; 2010 Mar; 375(9717):801-2; author reply 802-3. PubMed ID: 20206765
    [No Abstract]   [Full Text] [Related]  

  • 14. [Principles and methods for vaccine epidemiology: evaluation of immunogenicity and effectiveness of pandemic H1N1 influenza vaccine].
    Hara M; Ohfuji S; Fukushima W; Hirota Y
    Nihon Eiseigaku Zasshi; 2013; 68(3):153-60. PubMed ID: 24077487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influenza vaccination and intention to receive the pandemic H1N1 influenza vaccine among healthcare workers of British Columbia, Canada: a cross-sectional study.
    Kaboli F; Astrakianakis G; Li G; Guzman J; Donovan T; Naus M
    Infect Control Hosp Epidemiol; 2010 Oct; 31(10):1017-24. PubMed ID: 20707670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pandemic influenza H1N1 2009, innate immunity, and the impact of immunosenescence on influenza vaccine.
    Joshi SR; Shaw AC; Quagliarello VJ
    Yale J Biol Med; 2009 Dec; 82(4):143-51. PubMed ID: 20027279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The transmissibility and control of pandemic influenza A (H1N1) virus.
    Yang Y; Sugimoto JD; Halloran ME; Basta NE; Chao DL; Matrajt L; Potter G; Kenah E; Longini IM
    Science; 2009 Oct; 326(5953):729-33. PubMed ID: 19745114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modelling the effect of seasonal influenza vaccination on the risk of pandemic influenza infection.
    Mercer GN; Barry SI; Kelly H
    BMC Public Health; 2011 Feb; 11 Suppl 1(Suppl 1):S11. PubMed ID: 21356130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccination against pandemic influenza A/H1N1v in England: a real-time economic evaluation.
    Baguelin M; Hoek AJ; Jit M; Flasche S; White PJ; Edmunds WJ
    Vaccine; 2010 Mar; 28(12):2370-84. PubMed ID: 20096762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influenza virus infections from 0 to 2 years of age: A birth cohort study.
    Teros-Jaakkola T; Toivonen L; Schuez-Havupalo L; Karppinen S; Julkunen I; Waris M; Peltola V
    J Microbiol Immunol Infect; 2019 Aug; 52(4):526-533. PubMed ID: 29254653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.